Debt-to-equity of bioAffinity Technologies, Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
bioAffinity Technologies, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • bioAffinity Technologies, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 162%, a 111% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

bioAffinity Technologies, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 162% +86% +111% 30 Sep 2025
Q2 2025 365% +304% +496% 30 Jun 2025
Q1 2025 138% +98% +245% 31 Mar 2025
Q4 2024 93% +65% +237% 31 Dec 2024
Q3 2024 77% +60% +366% 30 Sep 2024
Q2 2024 61% +51% +507% 30 Jun 2024
Q1 2024 40% 31 Mar 2024
Q4 2023 27% 31 Dec 2023
Q3 2023 16% 30 Sep 2023
Q2 2023 10% 30 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.